On average, in the colon and lung cancer cell lines tested, the transcriptional program of c-Myc was the least redundant (6%), while the mutant p53 program was redundant in more than 50% of the cells in favor of mutant KRAS and/or c-Myc (Fig. 6D). This evidence concerns the gene MYC and lung carcinoma.